Anne Arundel Medical Center announces Barry Meisenberg, MD, as its new chair of the Department of Medicine.
Dr. Meisenberg has lead the Geaton and JoAnn DeCesaris Cancer Institute since 2008, and served as chair for Quality and Health Systems Research since 2012. He has been at the forefront of many health system initiatives and innovations in cancer care.
Dr. Meisenberg has also been instrumental in AAMC’s work to reduce opioid prescribing across the health system. Most recently, the Maryland Patient Safety Center recently awarded AAMC the Distinguished Achievement in Patient Safety Innovation Award.
“After a national search, our committee unanimously agreed that Dr. Meisenberg was the strongest candidate to lead our medical services into the future,” says Mitchell Schwartz, MD, chief medical officer and president of Physician Enterprise at AAMC. “He is a true leader in his field. We are honored to have him as an integral part of our health system team.”
In his new role as chair, Dr. Meisenberg will work to enhance quality outcomes and ensure that the Department of Medicine functions within an integrated system of care, continuously improving performance.
Prior to joining AAMC, Dr. Meisenberg was professor of Medicine at the University of Maryland School of Medicine. He also headed the Division of Hematology/Oncology and was deputy director for Clinical Affairs at the Marlene and Stewart Greenebaum Cancer Center.
Dr. Meisenberg is widely published in oncology and research journals, and speaks nationally and internationally on diverse topics in cancer medicine.
He is also a visiting professor of oncology at the Johns Hopkins Sidney Kimmel Cancer Center and supports their clinical efforts internationally.
Dr. Meisenberg received his medical degree from Albany Medical College in New York and completed his residency in internal medicine and a fellowship in Hematology/Oncology at the Naval Hospital in San Diego.
